Extrahepatic bile duct adenocarcinoma: Patients at high-risk for local recurrence treated with surgery and adjuvant chemoradiation have an equivalent overall survival to patients with standard-risk treated with surgery alone

Annals of Surgical Oncology

Volumn 15, Issue 11, 2008, Pages 3147-3156

  Borghero, Yerko ^a,b   Crane, Christopher H ^a   Szklaruk, Janio ^a   Oyarzo, Mauricio ^a   Curley, Steven ^a   Pisters, Peter W ^a   Evans, Douglas ^a   Abdalla, Eddie K ^a   Thomas, Melanie B ^a   Das, Prajnan ^a   Wistuba, Ignacio I ^a   Krishnan, Sunil ^a   Vauthey, Jean Nicolas ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

CAPECITABINE; CISPLATIN; FLUOROURACIL; GEMCITABINE;

ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; BRACHYTHERAPY; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER LOCALIZATION; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; DRUG WITHDRAWAL; EXTERNAL BEAM RADIOTHERAPY; EXTRAHEPATIC BILE DUCT ADENOCARCINOMA; FEMALE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; OVERALL SURVIVAL; PATIENT SAFETY; RISK ASSESSMENT; SKIN MANIFESTATION; SURGICAL RISK; SURVIVAL TIME; TREATMENT OUTCOME;

ADENOCARCINOMA; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BILE DUCT NEOPLASMS; BILE DUCTS, EXTRAHEPATIC; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE;

EID: 55149125586     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-008-9998-7     Document Type: Article

References (26)

1. J Klempnauer GJ Ridder R von Wasielewski 1997 Resectional surgery of hilar cholangiocarcinoma: a multivariate analysis of prognostic factors J Clin Oncol 15 947 54
2. P Neuhaus S Jonas 2000 Surgery for hilar cholangiocarcinoma-the German experience J Hepatobiliary Pancreat Surg 7 142 7
3. WG Kraybill H Lee J Picus 1994 Multidisciplinary treatment of biliary tract cancers J Surg Oncol 55 239 45
4. A Nakeeb KQ Tran MJ Black 2002 Improved survival in resected biliary malignancies Surgery 132 555 63
5. J Klempnauer GJ Ridder M Werner 1997 What constitutes long-term survival after surgery for hilar cholangiocarcinoma? Cancer 79 26 34
6. M Kayahara T Nagakawa T Ohta 1999 Role of nodal involvement and the periductal soft-tissue margin in middle and distal bile duct cancer Ann Surg 229 76 83
7. WR Jarnagin L Ruo SA Little 2003 Patterns of initial disease recurrence after resection of gallbladder carcinoma and hilar cholangiocarcinoma: implications for adjuvant therapeutic strategies Cancer 98 1689 700
8. P Neuhaus S Jonas WO Bechstein 1999 Extended resections for hilar cholangiocarcinoma Ann Surg 230 808 18
9. R Schoenthaler TL Phillips J Castro 1994 Carcinoma of the extrahepatic bile ducts. The University of California at San Francisco experience Ann Surg 219 267 74
10. M Urego JC Flickinger BI Carr 1999 Radiotherapy and multimodality management of cholangiocarcinoma Int J Radiat Oncol Biol Phys 44 121 6
11. HA Pitt A Nakeeb RA Abrams 1995 Perihilar cholangiocarcinoma. Postoperative radiotherapy does not improve survival Ann Surg 221 788 97
12. T Todoroki N Koike Y Morishita 2003 Patterns and predictors of failure after curative resections of carcinoma of the ampulla of Vater Ann Surg Oncol 10 1176 83
13. A Nakeeb HA Pitt TA Sohn 1996 Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors Ann Surg 224 463 73
14. Cancer Therapy Evaluation Program. Common terminology criteria for adverse events v3. Available at: http://ctep.cancer.gov/forms/CTCAEv3.pdf. Accessed May 30, 2008
15. Radiation Therapy Oncology Group. Cooperative group common toxicity criteria. Liver. Available at: http://www.rtog.org/members/toxicity/tox. html#liver. Accessed May 30, 2008
16. EL Kaplan P Meier 1958 Nonparametric estimation from incomplete observations J Am Stat Assoc 53 457 81
17. D González JP Gerard AW Maners 1990 Results of radiation therapy in carcinoma of the proximal bile duct (Klatskin tumor) Semin Liver Dis 10 131 41
18. ME Alden M Mohiuddin 1994 The impact of radiation dose in combined external beam and intraluminal Ir-192 brachytherapy for bile duct cancer Int J Radiat Oncol Biol Phys 28 945 51
19. CH Crane KO Macdonald JN Vauthey 2002 Limitations of conventional doses of chemoradiation for unresectable biliary cancer Int J Radiat Oncol Biol Phys 53 969 74
20. JJ Lu YS Bains M Abdel-Wahab 2002 High-dose-rate remote afterloading intracavitary brachytherapy for the treatment of extrahepatic biliary duct carcinoma Cancer J 8 74 8
21. H Bismuth MB Corlette 1975 Intrahepatic cholangioenteric anastomosis in carcinoma of the hilus of the liver Surg Gynecol Obstet 140 170 8
22. T Todoroki K Ohara T Kawamoto 2000 Benefits of adjuvant radiotherapy after radical resection of locally advanced main hepatic duct carcinoma Int J Radiat Oncol Biol Phys 46 581 7
23. DM Nagorney JH Donohue MB Farnell 1993 Outcomes after curative resections of cholangiocarcinoma Arch Surg 128 871 7
24. Y Nimura J Kamiya S Kondo 2000 Aggressive preoperative management and extended surgery for hilar cholangiocarcinoma: Nagoya experience J Hepatobiliary Pancreat Surg 7 155 62
25. Y Nimura N Hayakawa J Kamiya 1990 Hepatic segmentectomy with caudate lobe resection for bile duct carcinoma of the hepatic hilus World J Surg 14 535 43
26. AG Morganti L Trodella V Valentini 2003 Concomitant gemcitabine (Gemzar) and extended nodes irradiation in the treatment of pancreatic and biliary carcinoma: a phase I study Onkologie 26 325 9